Dynamic hyperinflation in chronic obstructive pulmonary diseases: Functional and clinical implications;Hiperinflación pulmonar en la enfermedad pulmonar obstructiva crónica: Importancia funcional y clínica

Revista Chilena de Enfermedades Respiratorias

Volumn 20, Issue 1, 2004, Pages 9-20

  Lisboa B , Carmen ^a   Borzone T , Gisella ^a   Díaz P , Orlando ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

COPD; Dyspnea; Exercise capacity; Expiratory flow limitation; Lung hyperinflation

Indexed keywords

EID: 12344326221     PISSN: 07175698     EISSN: 07177348     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. PAUWELS R A, BUIST A S, CALVERLEY P M A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO. Global initiative for chronic obstructive lung disease (GOLD). Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
2. American Lhoracic Society Statement. Standards for the diagnosis and care of patients with COPD. Am J Respir Crit Care Med 1995; 152: S78-S121.
3. Sociedad Chilena de Enfermedades Respiratorias. Consenso nacional en enfermedad pulmonar obstructiva cronica (EPOC). Rev Chil Enf Respir 1998; 14: 69-82.
4. HANSEN E F, PHANARETH K, LAURSEN LC, KOKJENSEN A, DIRKSEN A. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1267-71.
5. ELTAYARA L, BECKLAKE M R, VOLTA C A, MILIC-EMILI J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1726-34.
6. MAHLER D A, WELLS C K. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-6.
7. BAUERLE O, CHRUSCH C A, YOUNES M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998; 157: 57-68.
8. RENWICK D S, CONOLLY M J. Impact of obstructive airways disease on quality of life in older adults. Thorax 1996; 51: 520-5.
9. LISBOA C, VILLAFRANCA C, CAIOZZI G, BERROCAL C, LEIVA A, PINOCHET R et al. Calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica e impacto del entrenamiento físico. Rev Méd Chile 2001; 129: 359-66.
10. TAUBE C, LEHNIGK V, PAASCH K, JÖRRES R A, MAGNUSSEN H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilatation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 216-20.
11. KOULOURIS N G, VALTA P, LAVOIE A, CORBEIL C, CHASSÉ M, BRAIDY J et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995; 8: 306-13.
12. MILIC-EMILI J, DÍAZ O, MARANZZINI L, D'ANGELO E, LISBOA C. Espirometría forzada y curva flujo-volumen. Nuevos conceptos. Rev Chil Enf Respir 1998; 14: 15-24.
13. O'DONNELL D E, WEBB K A. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-7.
14. DÍAZ O, VILLAFRANCAC, GHEZZO H, BORZONE G, LEIVA A, MILIC-EMILI J et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-75.
15. MATSUBA K, WRIGHT J L, WIGGS B R, PARE P D, HOGG J C. The changes in airways structure associated with reduced forced expiratory volume in one second. Eur Respir J 1989; 2: 834-9.
16. MEAD J, TURNER J M, MACKLEM P T, LITTLE J B. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967; 22: 95-108.
17. LEAVER D G, PRIDE N B. Flow volume curves and expiratory pressures during exercise in patients with chronic airway obstruction. Scand J Respir Dis 1971; 77 (Suppl): S23-7.
18. GRIMBY G, ELGEFORS B, OXHOJ H. Ventilatory levels and chest wall mechanics during exercise in obstructive lung disease. Scand J Respir Dis 1973; 54: 45-52.
19. JOHNSON B D, REDDAN W G, PEGELOW D F, SEOW K G, DEMPSEY J A. Flow imitation and regulation of functional residual capacity during exercise in a physical active aging population. Am Rev Respir Dis 1991; 143: 960-7.
20. MONTES DE OCA M, RASULLO J, CELLI B R. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154: 1284-9.
21. TANTUCCI C, DUGUET A, SIMILOWSKI T, ZELTER M, DERENNE J-P, MILIC-EMILI. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients Eur Respir J 1998; 12: 799-804.
22. O'DONNELL D E, REVILL S M, WEBB K A. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-7.
23. DI MARCO F, MILIC-EMILI J, BOVERI B, CARLUCCI P, SANTUS P, CASANOVA F et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnea at rest in COPD. Eur Respir J 2003; 21: 86-94.
24. PRIDE N B, MACKLEM P T. Lung mechanics in disease. En: Macldem PT, Mead J., eds. The Handbook of Physiology. Section 3. The respiratory System Vol III. Part 2. Chapter 37. Bethesda, American Physiological Society 1986, pp 659-92.
25. QUANJER P H, TAMMELING G J, COTES J E, PEDERSEN O F, PESLIN R et al. Lung volumes and forced expiratory flows. Report of the working party: Standardization of lung function tests. European Community for Steel and Coal. Eur Respir J 1993; 6 (Suppl 16): 5-40.
26. STUBBING D G, PENGELLY L D, MORSE J L C, JONES N L. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-5.
27. LISBOA C, DÍAZ O, BORZONE G. Ventilatory factors in exercise performance in patients with COPD. En: The Physiological Basis of Respiratory Disease. Amid Q, Shannon J y Martin JG, eds. BC Decker. (En prensa).
28. DECRAMER M, GOSSELINK R, DEROM E. Respiratory muscle mechanics in chronic obstructive pulmonary disease and acute respiratory failure. En: Acute respiratory failure in chronic obstructive pulmonary disease. En: Derenne JP, Whitelaw WA, Similowski T, eds. Marcel Dekker, Inc., New York; pp 47-64.
29. DÍAZ O, VILLAFRANCA C, GHEZZO H, BORZONE G, LEIVA A, MILIC-EMILI J et al. Breathing pattern and gas exchange at peak exercise in COPD patients with and without flow limitation at rest 2001; 17: 1120-7.
30. KILLIAN K J, LEBLANC P, MARTIN D H, SUMMERS E, JONES N L, CAMPBELL J M. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-40.
31. O'DONNELL D E, BERTLEY J C, CHAU L K, WEBB K A. Qualitative aspects of exertional dyspnea in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-15.
32. MARÍN J M, CARRIZO S J, GASCÓN M, SÁNCHEZ A, GALLEGO B, CELLI B. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the six minutes- walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395-9.
33. BONI E, CORDA L, FRANCHINI D, CHIROLI P, DAMIÁN GP, PINI L et al. Volume effect of exertional dyspnea after bronchodilator in patients with COPD with and without flow limitation at rest. Thorax 2002; 57: 528-32
34. KILLIAN K J, INMAN K D, JONES N L. The thorax in exercise. En: Roussos C, ed. The Thorax. Second Edition. Part B: Applied Physiology. Chapter 47. Marcel Dekker, Inc. New York, 1995; pp: 1355-72.
35. REID R, DÍAZ O, JORQUERA J, LISBOA C. Efecto de la caminata de seis minutos sobre la hiperinflación pulmonar en pacientes con enfermedad pulmonar obstructiva crónica avanzada. Rev Méd Chile 2001; 129: 1171-8.
36. O'DONNELL D E, D'ARSIGNY C D, FITZPATRICK M, WEBB K A. Exercise hypercapnia in advanced chronic obstructive pulmonary disease. The role of lung hyperinflation Am J Respir Crit Care Med 2002; 166: 663-8.
37. 2 retention. Thorax 1998; 53: 768-74.
38. HADCROFT J, CALVERLEY P M A. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax 2001; 56: 713-20.
39. NEWTON M F, O'DONNELL D E, FORKET L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121: 1042-50.
40. O'DONNELL D E, FORKERT L, WEBB K A. Evaluation of bronchodilator response in patients with irreversible emphysema. Eur Respir J 2001; 18: 914-20
41. MANRÍQUEZ J, DÍAZ O, MENDOZA L, LISBOA C. Efectos de la administración de dos dosis de salbutamol (200 μg y 400 μg) sobre la obstrucción bronquial y la hiperinflación pulmonar en pacientes con EPOC avanzada. Rev Chil Enf Respir 2002; 18: 261.
42. BELMAN M J, BOTNICK W C, SHIN J W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-75.
43. O'DONNELL D E, LAM M, WEBB K A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-9.
44. JORQUERA J, DÍAZ O, LISBOA C. Efecto del bromuro de ipratropio sobre la hiperinflación pulmonar dinámica en pacientes con enfermedad pulmonar obstructiva crónica. Rev Méd Chile 2003; 131: 605-12.
45. COOPER J D, TRULOCK E P, TRIANTAFILLOU A N, PATTERSON G A, POHL M S, DELONEY P A et al. Bilateral pneumonectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-19.
46. COOPER J D, PATTERSON G A, SUNRADESAN R S, TRULOK E P, YUSEN R D, POHL M S et al. Results of 150 consecutive bilateral lung volume procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-30.
47. CRINER G J, CORDOVA F C, FURUKAWA S, KUZMA A M, TRAVALLINE J M, LEYENZON V et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 2018-27.
48. SCIURVA F C, ROGERS R M, KEENAN R J, SLIVKA W A, GORCSAN III J, FERSON P F et al. Improvement in pulmonary function and elastic recoil after lung reduction surgery for diffuse emphysema. N Eng J Med 1996; 334: 1095-9.
49. INGENITO E P, LORING S H, MOY M L, MENTZER S J, SWANSON S J, REILLY J J. Interpreting improvement in expiratory flows after lung volume reduction surgery in terms of flow limitation theory. Am J Respir Crit Care Med 2001; 163: 1074-80.
50. National emphysema treatment trial research group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-73.
51. GELB A F, MCKENNA R J, BRENNER M, SCHEIN M J, ZAMEL N, FISHEL R. Lung function 4 years after lung volume reduction surgery for emphysema. Chest 1999; 116: 1608-15.
52. CICCONE A M, MEYERS B F, GUTHRIE T J, DAVIS G E, YUSEN R D, LEFRACK S S et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 2003; 125: 513-25.
53. O'DONNELL D E, D'ARSIGNY C, WEBB K A. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-8.
54. ALVISI V, MIRKOVIC T, NESME P, GUERIN C, MILIC-EMILI J. Acute effects of hyperoxia on dyspnea in hypoxemic patients with chronic airway obstruction at rest. Chest 2003; 123: 1038-46.
55. DÍAZ O, BEGIN P, TORREALBA B, JOVER E, LISBOA C. Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 2002; 20: 1490-8.
56. ELLIOT M W, MULVEY D A, MOXHAM J, GREEN M, BRANTHWAITE M A. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J 1991; 4: 1044-52.